Cotillar, Jose T.
HRN: 21-21-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/26/2022
05/03/2022
IV
600mg
Q8
Open Wounds
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes